Aardvark Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DECHENG CAPITAL LLC | 08/14/2026 | 3.92 M | $22.56 M | 0.00% | 17.93% |
| CITADEL ADVISORS LLC | 09/02/2026 | 1.28 M | $7.39 M | 3.25% | 5.87% |
| LAURION CAPITAL MANAGEMENT LP | 08/13/2026 | 1.03 M | $5.96 M | 0.00% | 4.74% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 562.88 K | $3.24 M | 1.58% | 2.58% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 480.25 K | $2.77 M | 257.08% | 2.20% |
| ECOR1 CAPITAL, LLC | 08/14/2026 | 396.19 K | $2.28 M | 100.00% | 1.81% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 300.00 K | $1.73 M | 0.00% | 1.37% |
| BLACKROCK, INC. | 08/07/2026 | 187.05 K | $1.08 M | -76.40% | 0.86% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 149.84 K | $863.53 K | -51.58% | 0.69% |
| CANTOR FITZGERALD, L. P. | 08/19/2026 | 116.58 K | $671.51 K | 74.83% | 0.53% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 108.38 K | $624.25 K | -33.66% | 0.50% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2026 | 79.28 K | $456.68 K | 628.04% | 0.36% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 75.17 K | $432.99 K | -9.66% | 0.34% |
| WOODLINE PARTNERS LP | 08/14/2026 | 72.43 K | $417.19 K | 0.00% | 0.33% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 69.95 K | $402.90 K | -28.87% | 0.32% |
| STATE STREET CORP | 09/22/2026 | 59.27 K | $341.41 K | -70.26% | 0.27% |
| CITADEL ADVISORS LLC | 09/02/2026 | 59.10 K | $340.42 K | 11.72% | 0.27% |
| J. GOLDMAN & CO LP | 08/14/2026 | 40.50 K | $233.28 K | 100.00% | 0.19% |
| IEQ CAPITAL, LLC | 08/11/2026 | 38.38 K | $221.08 K | 132.83% | 0.18% |
| UBS GROUP AG | 08/13/2026 | 35.64 K | $205.28 K | -77.43% | 0.16% |
| MORGAN STANLEY | 08/13/2026 | 30.18 K | $173.82 K | 71.83% | 0.14% |
| NORTHERN TRUST CORP | 08/13/2026 | 28.08 K | $161.74 K | -68.31% | 0.13% |
| CITIGROUP INC | 08/03/2026 | 26.30 K | $151.48 K | -43.16% | 0.12% |
| CRESSET ASSET MANAGEMENT, LLC | 08/14/2026 | 24.03 K | $138.43 K | -44.44% | 0.11% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 24.03 K | $138.38 K | 100.00% | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2026 | 24.00 K | $138.24 K | -11.11% | 0.11% |
| JANE STREET GROUP, LLC | 08/14/2026 | 23.20 K | $133.63 K | 16.00% | 0.11% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2026 | 22.87 K | $131.74 K | 100.00% | 0.10% |
| JANE STREET GROUP, LLC | 08/14/2026 | 22.46 K | $129.39 K | 100.00% | 0.10% |
| MARINER, LLC | 08/13/2026 | 21.78 K | $125.41 K | 100.00% | 0.10% |
| SMITH, MOORE & CO. | 08/12/2026 | 20.00 K | $115.20 K | 100.00% | 0.09% |
| XTX TOPCO LTD | 08/14/2026 | 19.89 K | $114.56 K | -0.14% | 0.09% |
| MARSHALL WACE, LLP | 08/13/2026 | 19.08 K | $109.88 K | 100.00% | 0.09% |
| FMR LLC | 08/13/2026 | 18.90 K | $108.89 K | 111.03% | 0.09% |
| SIMPLEX TRADING, LLC | 08/12/2026 | 15.92 K | $91.68 K | 275.14% | 0.07% |
| ECOR1 CAPITAL, LLC | 08/14/2026 | 14.70 K | $84.67 K | 100.00% | 0.07% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 08/14/2026 | 12.43 K | $71.57 K | -59.44% | 0.06% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 12.24 K | $70.51 K | -36.92% | 0.06% |
| MERCER GLOBAL ADVISORS INC /ADV | 08/19/2026 | 11.46 K | $66.03 K | 100.00% | 0.05% |
| CERITY PARTNERS LLC | 08/14/2026 | 10.77 K | $62.04 K | 100.00% | 0.05% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 07/15/2026 | 10.43 K | $79.30 K | 100.00% | 0.05% |
| ABEL HALL, LLC | 07/24/2026 | 10.07 K | $57.98 K | 100.00% | 0.05% |
| SRS CAPITAL ADVISORS, INC. | 08/10/2026 | 8.37 K | $48.23 K | 34,791.67% | 0.04% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 5.89 K | $33.94 K | 0.00% | 0.03% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 08/13/2026 | 4.15 K | $23.90 K | 0.00% | 0.02% |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 07/24/2026 | 3.47 K | $20.00 K | -10.14% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 2.50 K | $14.41 K | -54.25% | 0.01% |
| BARCLAYS PLC | 08/14/2026 | 2.26 K | $13.01 K | -37.61% | 0.01% |
| INTEGRATED WEALTH CONCEPTS LLC | 08/12/2026 | 1.94 K | $11.19 K | 100.00% | 0.01% |
| JPMORGAN CHASE & CO | 08/12/2026 | 1.78 K | $9.24 K | -73.04% | 0.01% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aardvark Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 100 institutional investors and hedge funds held shares of Aardvark Therapeutics Inc.. The most heavily invested institutionals were:
Wealth Enhancement Trust Services, Inc.: 0
Decheng Capital LLC: 3.92 M
CITADEL ADVISORS LLC: 1.28 M
Laurion Capital Management LP: 1.03 M
VANGUARD CAPITAL MANAGEMENT LLC: 562,877
AQR CAPITAL MANAGEMENT LLC: 480,249
43.18% of Aardvark Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 10.18 M shares in the last 24 months. This purchase volume represents approximately $62.01 M in transactions.